Impressively, PARP1 mutation was markedly associated with higher levels of immune infiltrates, such as CD8+ T cells, in several tumor types, suggesting that tumors with PARP1 mutations could be classified as active immune subtypes. This evidence concerns the gene CD8A and neoplasm.